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Background: We conducted a randomized, double-blind, sham-controlled study to
assess the efficacy in motor recovery and safety of daily repetitive transcranial
magnetic stimulation (rTMS) in subacute stroke patients. Methods: Forty-one pa-
tients were randomly assigned to a real or sham stimulation group. Each patient
underwent regular rehabilitation accompanied by a series of 10 daily 5-Hz rTMS
of the ipsilesional primary motor cortex (M1) or sham stimulation. The primary
outcome was motor recovery evaluated by the Brunnstrom stages (BS). The sec-
ondary outcomes were improvement in the Fugl-Meyer Assessment (FMA), grip
power, National Institutes of Health Stroke Scale (NIHSS), Functional Indepen-
dence Measure (FIM), a quantitative measurement of finger tapping movement,
and the incidence of adverse events. Results: Thirty-nine patients completed the
study and were included in the analyses. The real rTMS group demonstrated ad-
ditional improvement in the BS hand score at the last follow-up compared to the
sham. The grip power, the NIHSS motor score, and the number of finger taps in
the affected hand improved in the real stimulation group but not in the sham
group. The BS upper limb scores, the FMA distal upper limb score, the NIHSS
total score, and the FIM motor score showed improvement from baseline at the
earlier time points after the real rTMS. There were no additional improvements
in the other scores after the real rTMS compared to the sham. No serious
adverse events were observed. Conclusions: Our results suggest that daily
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high-frequency rTMS of the ipsilesional M1 is tolerable and modestly facilitates
motor recovery in the paralytic hand of subacute stroke patients. Key Words:
Repetitive transcranial magnetic stimulation—motor cortex stimulation—
rehabilitation—subacute stroke—stroke recovery—randomized controlled trial.
© 2016 The Authors. Published by Elsevier Inc. on behalf of National Stroke
Association. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Poststroke motor disturbance not only reduces the quality
of life and activities of daily living of patients but also
has a great social impact through lost productivity. With
this in mind, efforts have been made to improve the func-
tional outcomes of poststroke patients undergoing
rehabilitation. One such approach is repetitive transcranial
magnetic stimulation (rTMS), with the purpose of facili-
tating poststroke recovery of motor function. Two common
approaches have been advocated. One of these is low-
frequency rTMS (1 Hz or less) to the contralesional primary
motor cortex (M1) area to decrease excessive excitabili-
ty and thus decrease excessive interhemispheric inhibition
to the ipsilesional side. The other approach involves
high-frequency rTMS (greater than 1 Hz), or excitatory
stimulation, to facilitate the decreased cortical excitabil-
ity on the stroke-affected side.1-4 In the past, there have
been a variety of reports on the use of low-frequency rTMS
to the contralesional M1,2,4-8 and high-frequency rTMS to
the ipsilesional M11-3,6-12 with the purpose of neuroreha-
bilitation. About half of these studies have involved chronic
stage infarction patients.2,4,5,7,10-12 Although some studies
have shown improvements in acute stroke patients both
as a result of low-frequency contralesional stimulation and
as a result of high-frequency ipsilesional stimulation,3,6,8,9
a few randomized double-blind controlled trials have in-
vestigated the efficacy of high-frequency ipsilesional
stimulation in subacute stroke patients.8 As functional re-
covery after stroke is said to be most pronounced in the
period within 3 months after onset,13 we postulated that
rather than rTMS at the chronic stage, the add-on effects
of rTMS may be greater when it is applied at an earlier
stage. To study the add-on effects of rTMS on ischemic
and hemorrhagic subacute stroke patients, we under-
took a randomized, double-blind, parallel study to test
the hypothesis that 10 sessions of daily rTMS, com-
bined with regular rehabilitation, improve the results of
recovery of motor function in subacute stroke patients.
Methods
Patients
This was a randomized, double-blind, sham-controlled,
parallel study conducted at 3 centers (a university hos-
pital and 2 rehabilitation hospitals) in Japan from September,
2010, to December, 2012. We enrolled patients with the
following conditions: (1) 20 years old and over, (2) motor
disturbances in the upper limb caused by ischemic or hem-
orrhagic stroke (Brunnstrom stages [BS]14 arm ≤ 5 or BS
hand ≤ 5), and (3) within 8 weeks of stroke onset. The
following conditions excluded patients from participat-
ing in the present study: (1) total paralysis of the upper
limb (BS arm = 1 and BS hand = 1); (2) contraindications
to transcranial magnetic stimulation, such as the implan-
tation of a cardiac pacemaker; (3) previous rTMS; (4) aphasia,
dementia, psychological disorders, or suicidal wishes; (5)
a history of epilepsy; and (6) pregnancy.
This randomized controlled study was conducted in
accordance with the Declaration of Helsinki and Japa-
nese ethical guidelines for clinical studies. The study protocol
was thoroughly reviewed and approved by the institu-
tional review boards and the ethics committees of all the
participating institutions (approval number, 09278-2). The
protocol was finalized on September 1, 2010, and this clin-
ical trial was registered with the Japanese University Hospital
Medical Information Network Clinical Trials Registry,
number UMIN000007594. All patients provided written
informed consent and approval before enrollment.
Randomization
The participants were recruited from 2 hospitals spe-
cializing in rehabilitation, where they received daily
rehabilitation. Randomization was performed using a
computer-generated permuted-block method by a third-
party statistician upon confirmation of patient eligibility,
prior to the start of the study. Patients were randomly
assigned to 1 of 2 treatment groups (real rTMS plus regular
rehabilitation therapy versus sham stimulation plus regular
rehabilitation therapy) according to age (<65 and ≥ 65 years
old), severity of symptoms (BS hand score ≤ 3 [severe]
and ≥ 4 [mild]), and institution. The patients were iden-
tified by sequential numbers assigned at randomization.
An assignment notice was sent only to investigators who
conducted the rTMS intervention. The patients and as-
sessors were blinded to group assignment until the study
was completed.
Procedures
Stimulation sessions were undertaken daily for 10 con-
secutive days except for weekends, after which follow-
up evaluations were undertaken over the next 2 weeks
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at each rehabilitation hospital. In principle, the stimula-
tion began on a Monday (day 1) and finished on the Friday
of the following week (day 12), with follow-ups until the
Monday of the fourth week (day 29). Standard rehabil-
itation was undertaken on a daily basis, including
weekends and public holidays, during and after the study
period. Physical therapy and occupational therapy were
provided, with speech therapy also undertaken by pa-
tients who required it. Therapies started in most cases
within 1 hour of the completion of rTMS sessions. Daily
rehabilitation consisted of 8 therapy sessions each lasting
for 20 minutes. Of these sessions, occupational therapy
made up 3 sessions per day, including gross motor train-
ing in the proximal upper extremity, motor training of
hand dexterity, training of coordinated movement with
both hands, and practices for activities of daily living.
The evaluations were performed by assessors who were
blinded to the group assignment. Figure 1 shows the time
schedule of the evaluations. All evaluations except for
the finger tapping measurement were undertaken prior
to rehabilitation sessions at baseline, and on days 5 (As-
sessment 1), 12 (Assessment 2), and 29 (Assessment 3).
They included BS arm, BS hand, BS lower limb,14 Fugl-
Meyer Assessment (FMA) total score, FMA proximal upper
limb score (shoulder, elbow, and forearm motor func-
tions), FMA distal upper limb score (wrist and hand motor
functions),15 handgrip of both hands, National Institutes
of Health Stroke Scale (NIHSS) total score, NIHSS motor
arm score,16 Functional Independence Measure (FIM) motor
score, and FIM cognitive score.17 Three days prior to
the start of stimulations, objective estimations of finger
tapping movements were obtained using a system with
magnetic sensors (UB-1; Finger Tapping Movement Ana-
lyzer; Hitachi Corporation, Tokyo, Japan) that continuously
monitored the distance between 2 coils via a calibration
method.18 Using this system, we quantitatively mea-
sured the total distance traveled, the mean maximum
amplitude, the mean maximum opening velocity, the mean
maximum closing velocity, an estimate of total con-
sumed energy (sum of squares of velocity), and the number
of finger taps during 30 seconds with respect to the move-
ment of the index finger and the thumb of both hands.19
The same tests were undertaken after the full comple-
tion of the individual’s stimulation series (days 15-17).
Prior to the stimulation period, the location of the M1
hand knob in the affected hemisphere was located using
a transcranial magnetic stimulation navigation system
(Brainsight; Rogue Research Inc., Montreal, Quebec, Canada).
This location was then marked on the scalp and mea-
sured so that the same location could be rapidly determined
without a navigation system. The rTMS was applied using
a figure-8 coil (MC B-70; Medtronic Functional Diagnos-
tics A/S, Skovlunde, Denmark; or no. 9925-00; Magstim
Co Ltd, Whitland, United Kingdom) connected to a mag-
netic stimulator (MagPro, Medtronic Functional Diagnostics
A/S; or Magstim Rapid, Magstim), which provided re-
petitive biphasic pulses. The patients were positioned in
the supine position, and their heads were fixed. The pre-
determined target was located from the previously made
marking, and fine adjustments in the coil location were
made to confirm the optimal spot according to visual de-
tection of muscle twitches if muscle twitches were observed.
The resting motor threshold was defined as the minimal
intensity necessary to induce at least 1 visible muscle twitch
in the affected hand on a session by session basis, which
corresponds to that determined using an electromyogram,20
and the intensity of real rTMS was set to 90% of the resting
motor threshold for that day. In patients without muscle
twitches, the intensity of the real rTMS was set to 100 A/
μs for the MagPro or maximum output for the Magstim
Rapid, which is approximately equivalent to the stimu-
lus intensity. Five hundred pulses per session were delivered
to the M1 hand in the affected hemisphere (10 trains of
5 Hz for 10 seconds with a 50-second intertrain interval).
Sham stimulations were applied with the same param-
eters as real stimulations, but the coil was placed at a 90°
angle to the scalp.21 Standard guidelines on the safe use
of rTMS were followed in the present study.22
The finger tapping measurement and the localization
of the M1 hand knob were undertaken at Osaka Uni-
versity Hospital. Other evaluations, daily rTMS, and
rehabilitation were undertaken at the 2 rehabilitation
hospitals.
Statistical Analysis
The primary end point was the BS. The secondary end
points were the FMA score, handgrip strength score, NIHSS
Figure 1. The intervention and evaluation schedule. Abbreviations: BS,
Brunnstrom stage; FIM, Functional Independence Measure; FMA, Fugl-
Meyer Assessment; NIHSS, National Institutes of Health Stroke Scale; rTMS,
repetitive transcranial magnetic stimulation.
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score, FIM score, the finger tapping measurement, and
the incidence of adverse events. A target number of 20
real and 20 sham subjects were decided upon based on
a previous rTMS study,6 from which we expected BS im-
provements of 1.3 in a real stimulation group and of .35
in a sham stimulation group with the same standard de-
viation of 1.0. We calculated this sample size with a power
of 80% at an α level of .05 to detect the effect of rTMS,
allowing for a drop-out rate of 5%. The projected study
period was 2 years, and no interim analysis was planned.
Differences in baseline patient characteristics and scores
between the 2 assigned groups were assessed with a
2-sample t-test for continuous data, Mann–Whitney’s U-test
for ordinal data (BS, FMA, NIHSS, and FIM scores), and
Fisher’s exact test for nominal data. Regarding analyses
of rTMS efficacy, first, the improvement over time with
respect to baseline scores was evaluated in each group
using a paired t-test for the finger tapping measure-
ment, a repeated measures analysis of variance (within-
subject factor, day [baseline, days 5, 12, and 29]) for
handgrip, and Friedman test for the other evaluations with
ordinal scales (BS, FMA, NIHSS, and FIM). Second, in
the improved scores except for the finger tapping mea-
surement, we used the Dunnett multiple comparisons or
Wilcoxon signed rank tests with the Bonferroni correc-
tion as post hoc analyses to evaluate improvement from
the baseline score at each time point after stimulation.
Third, differences in the improvement at the last evalu-
ation time point between the 2 groups were evaluated
by a 2-sample t-test for the finger tapping measurement
and handgrip and Mann–Whitney’s U-tests for the other
evaluations. For all comparisons, findings with P values
less than .05 were considered statistically significant. Data
were analyzed with the JMP Pro 11.2.1 software (SAS In-
stitute Inc., Cary, NC), and the Statistics Toolbox
implemented in MATLAB 8.3.0 (MathWorks Inc., Natick,
MA).
Results
Figure 2 shows the trial profile. Forty-one patients
were enrolled in the present study. Twenty patients
were assigned to the real stimulation group and 21 to
the sham stimulation group. Two subjects in the real
stimulation group failed to complete the study. One patient
did not like the stimulation sensation on the scalp after
one 10-second train of stimulations on the first day of
stimulations, and declined following stimulations. The
other patient also temporarily refused other forms of
treatment such as regular rehabilitation during the first
week of the stimulation. Thirty nine patients were finally
included in the analysis after the removal of these 2
patients because evaluations could not be performed at
all after the beginning of interventions. Table 1 shows
the baseline patient characteristics of the 39 patients ana-
lyzed. The mean age of the participants was 62.9 ± 13.8
years old, and the mean postonset duration at the start
of the intervention was 45.5 ± 9.0 days (range, 25-56 days).
One patient with partial damage of the M1 hand area
was included in each group. There were no differences
in the baseline characteristics, scores, and lesion size
between the real and sham stimulation groups, except
for the FIM cognitive score.
Improvements in the BS (Primary Outcome)
The BS of all regions (arm, hand, and lower limb) im-
proved significantly over time with respect to baseline
scores for both real and sham stimulation groups (Table 2).
Figure 3 indicates changes over baseline scores in the BS.
The multiple comparisons showed that the real stimu-
lation group achieved earlier improvement from baseline
in the BS arm and hand scores when compared to the
sham stimulation group. The BS arm score was signifi-
cantly improved at day 29 in the real stimulation group
but not in the sham stimulation group. The BS hand score
was significantly improved at days 12 and 29 in the real
stimulation group but only at day 29 in the sham stim-
ulation group. The BS lower limb score did not show a
significant improvement at any of the time points after
stimulation (Table 3). Improvement over baseline scores
in the BS hand score at day 29 was significantly greater
in the real stimulation group than in the sham stimula-
tion group (P = .037). Although improvement in the BS
arm score tended to be greater in the real stimulation
group, the difference between the real and sham groups
was not significant for the arm and lower limb scores
(P = .294 and P = .747, respectively).
Improvements in the FMA, Handgrip Strength,
NIHSS, and FIM Scores
The FMA total score, FMA proximal upper limb score,
FMA distal upper limb score, NIHSS total score, and FIM
subscores improved significantly over time with respect
to baseline scores for both real and sham stimulation
Figure 2. Trial profile. Flowchart shows the organizational structure of
the study, with the number of patients initially enrolled (n = 41), and the
number of patient dropouts during the study. The final number of pa-
tients in each assigned group is indicated.
1658 K. HOSOMI ET AL.
groups. Handgrip strength scores for the nonaffected hand
did not significantly improve over time for the real or
for the sham stimulation group. Meanwhile, in the af-
fected hand, only the real stimulation group showed an
improvement in handgrip strength score. The NIHSS motor
arm score significantly improved only in the real stim-
ulation group but not in the sham stimulation group
(Table 2). The multiple comparisons showed that the real
stimulation group achieved earlier improvement from base-
line in the FMA distal upper limb score, NIHSS total score,
and FIM motor score when compared to the sham stim-
ulation group. The FMA distal score significantly improved
at days 12 and 29 in the real stimulation group but only
at day 29 in the sham stimulation group. The NIHSS total
score was significantly improved at all time points in the
real stimulation group but not in the sham stimul ation
group (Table 3). There were no significant differences
between the real and sham stimulation groups in im-
provements in any of the secondary end points over
baseline scores at day 29.
Finger Tapping Motion
There was a significant increase in the number of taps
made in the real stimulation group (P = .006), whereas
no significance was observed in the sham stimulation group
(P = .092). The change from the baseline was not signifi-
cantly different between the 2 groups (P = .068). No
significant improvement was seen in the total distance
traveled, mean maximum amplitude, mean maximum
opening velocity, mean maximum closing velocity, or the
estimate of total consumed energy (Table 4).
Table 1. Patient characteristics
Characteristics Real (n = 18) Sham (n = 21) P value
Sex (female), n (%) 8 (44) 8 (38) .94
Age (years) 62.4 (15.5) 63.2 (12.5) .87
Type of stroke, n (%)
Hemorrhage 6 (33) 9 (43) .78
Infarction 12 (67) 12 (57)
Distribution of stroke lesion, n (%)
Subcortex 17 (94) 16 (71) .26
Involvement of cortex 1 (6) 5 (29)
Affected hemisphere
Right 11 13 .78
Left 7 8
Postonset duration (days) 46.1 (8.7) 45.1 (9.5) .79
Brunnstrom stages
Arm 3.8 (1.1) 4.0 (1.3) .52
Hand 3.6 (1.5) 3.7 (1.5) .87
Lower limb 4.6 (1.2) 4.4 (1.4) .74
Fugl-Meyer Assessment score
Total 176.3 (29.6) 169.1 (37.9) .92
Motor 62.3 (23.9) 61.9 (28.4) .96
Handgrip strength score (kg)
Affected hand 4.9 (5.7) 7.1 (8.6) .38
Nonaffected hand 26.1 (9.1) 26.3 (9.6) .94
NIHSS score 4.4 (2.8) 4.6 (3.2) .99
FIM score
Motor 63.9 (13.4) 62.7 (17.6) .92
Cognitive 31.8 (4.8) 28.8 (4.6) .02*
Resting motor threshold (%)† 67.7 (16.1) 72.5 (16.0) .62
Study hospital
A 10 13 .94
B 8 8
Abbreviations: FIM, Functional Independence Measure; NIHSS, National Institutes of Health Stroke Scale; SD,
standard deviation.
Data are means (SD), numbers (%), or numbers. There were no differences in the baseline characteristics and scores
between real and sham stimulation groups.
*Significant difference between 2 groups.
†Resting motor threshold is shown as percentage of maximum output. Data from 7 patients in each group because
of an absence of motor evoked potentials and motor twitches.
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Table 2. Results of clinical scores
Clinical scores Baseline Day 5 Day 12 Day 29 P value
Brunnstrom stages Arm Real 4 [3-5] 4 [3.3-5] 4 [4-5] 5 [4-5] <.001*
3.8 (1.1) 3.9 (1.0) 4.2 (1.1) 4.3 (1.2)
Sham 5 [3-5] 5 [3-5] 5 [3-5] 5 [3-5] .004*
4.0 (1.3) 4.0 (1.3) 4.2 (1.2) 4.3 (1.2)
Hand Real 4 [2-5] 4 [3-5] 5 [3.3-5] 5 [4-5] <.001*
3.6 (1.5) 3.9 (1.1) 4.2 (1.1) 4.4 (1.2)
Sham 4 [2-5] 4 [2-5] 4 [3-5] 4 [3-5] .001*
3.7 (1.5) 3.9 (1.5) 4.0 (1.4) 4.1 (1.4)
Lower limb Real 5 [4-5.8] 5 [4-6] 5 [4.3-6] 5 [5-6] .013*
4.6 (1.2) 4.7 (1.2) 4.8 (1.2) 4.9 (1.0)
Sham 5 [3-6] 4 [4-6] 5 [4-6] 5 [4-6] .004*
4.4 (1.4) 4.5 (1.2) 4.7 (1.2) 4.8 (1.2)
Fugl-Meyer Assessment score Total Real 183 [158-198] 185 [170-201] 193.5 [176-209] 194 [172-211] <.001*
Sham 174 [133-205] 191 [138-208] 187 [158-209] 191 [163-211] <.001*
Proximal upper limb Real 26.5 [19-32] 30 [20-34] 31.5 [22-34] 31.5 [21-35] <.001*
Sham 25 [11-35] 29.5 [12-35] 29 [14-35] 33 [16-36] <.001*
Distal upper limb Real 13 [2.3-22] 13.5 [3.8-22] 15 [4.8-22] 17 [3-22] <.001*
Sham 12 [2-20] 18 [2-23] 18 [3-22] 17 [2.8-23] <.001*
Handgrip strength score (kg) Affected hand Real 4.9 (5.7) 5.4 (5.5) 6.1 (5.9) 6.5 (6.8) .041*
Sham 7.1 (8.6) 7.8 (8.4) 8.2 (8.9) 8.3 (8.6) .077
Nonaffected hand Real 26.1 (9.1) 27.2 (8.0) 27.3 (8.8) 27.7 (8.4) .159
Sham 26.3 (9.6) 26.4 (9.7) 25.7 (9.7) 26.8 (9.8) .388
NIHSS score Total Real 3.5 [2.3-6] 3 [2-5] 3 [1-4.8] 2 [1-4.8] <.001*
Sham 3 [2-7] 3 [2-6] 3 [1-6] 3 [1-6] .004*
Motor arm Real 2 [0-2] 1 [0-2] 0 [0-2] 0 [0-2] <.001*
Sham 0 [0-3] 0 [0-2] 0 [0-2] 0 [0-2] .097
FIM score Motor Real 65 [53-75] 68 [56-75] 69 [61-79] 71 [64-80] <.001*
Sham 64 [48-78] 71 [52-81] 71 [52-80] 73 [55-82] <.001*
Cognitive Real 34 [31-35] 34 [31-35] 34 [31-35] 35 [31-35] .003*
Sham 28 [25-34] 29 [25-34] 31 [26-34] 31 [27-35] <.001*
Abbreviations: FIM, Functional Independence Measure; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; SD, standard deviation.
Data are expressed as medians [IQR] or means (SD). Both medians and means are indicated for each score of the Brunnstrom stages. Improvement over time with respect to a baseline score was
statistically evaluated and each P value is shown.
*Significant improvement over time with respect to baseline.
1660
K
.
H
O
SO
M
I
E
T
A
L.
Adverse Events
There were no serious adverse effects observed during
or after the stimulations during the 2-week follow up
period after completion of stimulations. As was previ-
ously mentioned, 1 subject withdrew from the protocol
due to uncomfortableness. Incidentally, he later appar-
ently demanded continuation of stimulations, after which
he reportedly found the same stimulation pattern relax-
ing and enjoyable.
Discussion
This double-blind randomized controlled study of daily
rTMS targeting the M1 hand area demonstrated a facili-
tation effect on motor recovery in the paralytic hand of
subacute ischemic and hemorrhagic stroke patients without
any serious adverse events. The real stimulation provid-
ed better improvement in the BS hand score at the last
follow-up compared to the sham. The handgrip strength
score, the NIHSS motor arm score, and the number of
taps significantly improved only after the real stimula-
tion. The real stimulation showed earlier improvement
in the BS arm score, BS hand score, FMA distal upper
limb score, NIHSS total score, and FIM motor score.
However, it did not show an effect on motor recovery
in the paralytic leg, or scores for activities of daily living.
The effect of rTMS on poststroke motor recovery has
been studied in around a dozen articles, in which high-
frequency rTMS on the ipsilesional M11-3,6-12 or low-
frequency rTMS on the contralesional M12,4-8 was applied
according to the interhemispheric balance hypothesis. A
recent meta-analysis reported that rTMS had a positive
effect on motor recovery in patients with stroke, espe-
cially for those with subcortical stroke.23 Among these
studies using high-frequency rTMS, 3 studies from the
same group involved poststroke patients at the acute
stage,3,6,9 one at the subacute stage,1 three at the chronic
stage,7,10,12 as well as two at various stages.2,11 Two studies
for chronic stage patients failed to demonstrate any pos-
itive effects of high-frequency rTMS on motor function,7,12
whereas the others reported positive effects. However, three
of these were non- or pseudorandomized studies,1,10,11 and
the others were regarded as having an unclear risk of
selection bias in random sequence generation and/or al-
location concealment procedures by the Cochrane review
and meta-analysis.24 A recent evidence-based guideline
issued by a group of European experts stated there may
be a possible effect of low-frequency rTMS on the
contralesional M1 in acute motor stroke (recommenda-
tion level C) and a probable effect in chronic motor stroke
(level B), while there may be a possible effect from high-
frequency rTMS on the ipsilesional M1 in acute and chronic
motor stroke (level C).25 In our study, additional im-
provements in motor function were demonstrated in a
double-blind, randomized manner. The results from our
study indicated that the benefits of rTMS were more lo-
calized to the particular area being stimulated, in our cases,
the affected hand (stimulation of the M1 hand knob). This
finding is consistent with the results of a previous report,
which tested the effects of high-frequency rTMS on the
M1 corresponding to the paretic hand in poststroke pa-
tients in the subacute period.1 Chang et al. reported that
real rTMS, in conjunction with motor practice, had pro-
duced a greater improvement in the arm score of the
Motricity Index, but not in the lower limb score, up to
3 months after onset of stroke. Moreover, grip strength
Figure 3. Improvements in the BS score. Improvement over baseline scores
in the BS of the arm (A), hand (B), and lower limb (C). The BS arm score
significantly improved at day 29 in the real stimulation group but not in
the sham stimulation group. The BS hand score significantly improved at
days 12 and 29 in the real stimulation group, but only at day 29 in the
sham stimulation group. The BS lower limb score did not show a signif-
icant improvement at any of the time points after stimulation. Improvement
over baseline scores in the BS hand score at day 29 was significantly greater
in the real stimulation group than in the sham group (P = .037). However,
the difference between the 2 groups at day 29 was not significant for the
other scores. Abbreviation: BS, Brunnstrom stage; *, P < .05; **, P < .001;
real; sham.
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in the affected hand improved only in the real stimula-
tion group over baseline in that study. Sasaki et al8 also
reported improvement in grip strength and finger tapping
frequency in acute or subacute stroke patients after a
5-session high-frequency rTMS, which is consistent with
our results. Our results could reinforce the evidence of
the positive effects on motor recovery after multisession
high-frequency rTMS during the subacute period while
the patient was undergoing rehabilitation.
We focused on the subacute period after stroke in the
present study, because the period within several months
after stroke onset is thought of as a golden period for
initiating exogenous restorative therapies, as endog-
enous repair-related events reach peak levels,13 and
Table 3. Results of multiple comparisons
Clinical scores
P value
Day 5 Day 12 Day 29
Brunnstrom stages Arm Real 1.000 .094 .023*
Sham 1.000 .375 .094
Hand Real .211 .003* <.001*
Sham .375 .094 .047*
Lower limb Real 1.000 .188 .094
Sham 1.000 .094 .229
Fugl-Meyer Assessment score Total Real .003* <.001* <.001*
Sham .002* <.001* <.001*
Proximal upper limb Real .045* .007* .003*
Sham .035* .018* .003*
Distal upper limb Real .709 .004* .006*
Sham .182 .051 .002*
Handgrip strength score (kg) Affected hand Real .795 .136 .024*
NIHSS score Total Real .041* .006* .006*
Sham 1.000 .076 .053
Motor arm Real .094 .012* .047*
FIM score Motor Real .001* <.001* .001*
Sham .070 <.001* <.001*
Cognitive Real .375 .188 .047*
Sham 1.000 .188 .012*
Abbreviations: FIM, Functional Independence Measure; NIHSS, National Institutes of Health Stroke Scale.
Improvement from a baseline score was statistically evaluated by multiple comparisons and each P value is shown.
*Significant improvement from a baseline score.
Table 4. Finger tapping measurement
Measurement items Baseline Post stimulation
Total distance (mm) Real 2608 (3001) 3568 (3832)
Sham 3759 (3904) 3866 (3986)
Mean maximum amplitude (mm) Real 44.4 (38.1) 33.3 (25.7)
Sham 50.1 (35.3) 41.3 (35.0)
Mean maximum opening velocity (m/s) Real .35 (.45) .33 (.34)
Sham .33 (.35) .36 (.38)
Mean maximum closing velocity (m/s) Real .35 (.41) .40 (.40)
Sham .48 (.50) .43 (.41)
Total energy† Real 140 (228) 199 (328)
Sham 220 (303) 226 (309)
Number of taps Real 20.7 (20.1) 39.2* (33.3)
Sham 26.6 (23.6) 32.4 (30.9)
Data are expressed as means (SD).
*The number of taps significantly increased in the real stimulation group (P = .006).
†Sum of squares of velocity.
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functional reorganization and plastic changes are seen in
the brain.26 In other studies, earlier neurorehabilitation
has been proven to result in better outcomes,27 and most
improvement generally occurs within the first 3 months
after stroke onset.13 Moreover, high-frequency rTMS on
the ipsilesional M1 demonstrated favorable results for the
acute stage in poststroke patients,3,6,8,9 whereas no sig-
nificant benefit for the chronic stage was seen in 2
studies.7,12 This would indicate that high-frequency rTMS
should probably be initiated at least by the subacute period.
A recent study has suggested a spinal mechanism for
the effect of rTMS. It is reported that high-frequency rTMS
of the ipsilesional M1 had suppressed F-waves, which
was presumed to result from an enhanced inhibitory effect
on spinal excitability.28 In our study, the quantitative mea-
surement of finger tapping movement showed that
significant increases were seen in the number of taps in
the real stimulation group, which has also been ob-
served in a previous study.8,11 This may be partially due
to the attenuation of spasticity after high-frequency rTMS.
In the present study, the direct comparison between
the real and sham stimulation groups revealed that the
significant, but modest, positive effect was limited to im-
provement in the BS hand score. Although components
of the upper limb in other scores tended to show greater
improvement after the real stimulation, there were no
significant differences in FMA, NIHSS, and FIM scores
between the 2 groups. Similar findings were seen in the
above-mentioned study reported by Chang et al.1 Addi-
tional motor recovery seen in the present study was still
modest; therefore, the efficacy of rTMS needs to be im-
proved. To improve the efficacy of rTMS, there are some
possible methods that can be utilized. As suprathreshold
stimulation has been said to provide more favorable
results,3,6,9 the efficacy of rTMS may be improved by a
higher intensity of stimulation within the guidelines on
the safe use of rTMS. Moreover, some researchers have
recently examined the efficacy of coupling inhibitory and
facilitatory rTMS suggesting more favorable outcomes when
compared to single-session rTMS alone.7
One of major clinical advantages of rTMS is its non-
invasive nature. The present study and previous studies
have not reported any serious adverse events after rTMS
for the treatment of poststroke patients.23 The use of daily
high-frequency rTMS during the subacute period seems
to be safe in poststroke patients.
Our study has several potential limitations. First, our
study was limited to evaluations over 4 weeks. Out-
comes over a longer follow-up period should be considered
for evaluation in future studies. Second, the small pos-
itive result in the BS hand score should be interpreted
with caution. The dissociation between the results of the
BS hand score and FMA distal upper limb score may be
caused by the difference in characteristics of each score;
the BS score is a 6-point scale, whereas the FMA distal
upper limb score consists of 3-point scales in 8 motor
tasks (total score of 24). Alternatively there is a possi-
bility of overestimation due to rough evaluation of BS.
Third, baseline cognitive condition in activities of daily
living was unbalanced in the allocated groups. The stroke
type and location of our subjects was heterogeneous, and
the number of subjects was small for subgroup analy-
sis. Three stratification factors were not optimal for the
small number of subjects in the present study. Further
studies in larger populations with optimal stratification
factors such as a stroke location should be conducted to
clarify the various roles of rTMS in poststroke patients.
Conclusions
Our results suggest that daily high-frequency rTMS of
the ipsilesional M1 is tolerable and modestly facilitates
motor recovery in the paralytic hand of subacute isch-
emic and hemorrhagic stroke patients. Further studies
investigating more effective conditions are also required
to establish rTMS therapy as a practical clinical utility.
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